Amber N. Stratman on Muck Rack

Amber N. Stratman

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Amber N.

Contact Amber N., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

FAM210B is dispensable for erythroid differentiation in adult mice

|
By Mark Perfetto, Catherine M. Rondelli, Amber N. Stratman, Samantha Gillis
| biorxiv.org
Abstract Iron plays a central role in cellular redox processes, but its ability to adopt multiple oxidation states also enables it to catalyze deleterious reactions. The requirement for iron in erythropoiesis has necessitated the evolution of mechanisms with which to handle the iron required for hemoglobinization. FAM210B was identified as a regulator of mitochondrial iron import and heme synthesis in erythroid cell culture and zebrafish models.
Open in Who Shared Issue with article?

Identification of overlapping and distinct mural cell populations during early embryonic development

|
By Amber N. Stratman, Sarah Colijn, Miku Nambara
| biorxiv.org
Thank you for your interest in spreading the word about bioRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. Message Subject (Your Name) has forwarded a page to you from bioRxiv Message Body (Your Name) thought you would like to see this page from the bioRxiv website.
Open in Who Shared View Duplicates (696) Issue with article?

Anti-angiogenic effects of VEGF stimulation on endothelium deficient in phosphoinositide recycling

|
By J. Silvio Gutkind, Brant M. Weinstein, Olivia Farrelly, Amber N. Stratman
| Nature Verified
Abstract Anti-angiogenic therapies have generated significant interest for their potential to combat tumor growth. However, tumor overproduction of pro-angiogenic ligands can overcome these therapies, hampering success of this approach.
Open in Who Shared Issue with article?
See all 3 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified